# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Morgan Stanley analyst Erik Woodring maintains IBM (NYSE:IBM) with a Equal-Weight and lowers the price target from $186 to $...
IBM announced agreements with the Canadian government to develop semiconductor capabilities, despite positive remarks from Prim...
Up to $187M CAD to be invested to progress expansion of chip packaging capacity and capabilities and to strengthen R&D at I...
JP Morgan analyst Brian Essex maintains IBM (NYSE:IBM) with a Neutral and lowers the price target from $190 to $185.
Wall Street suffers a double blow in Thursday’s session, as softer-than-expected revenue forecasts from Meta Platforms Inc. (NA...
BMO Capital analyst Keith Bachman maintains IBM (NYSE:IBM) with a Market Perform and lowers the price target from $210 to $190.
To gain an edge, this is what you need to know today.